Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib taken by mouth helps treat hair loss in children.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Fetuin A may increase collagen production and promote scarring.

Fusaric acid may help control Orobanche ramosa by activating plant defenses.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.